Cancer Drug Resistance
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.
Authors of Review and Research Articles published in 2023-2024 have a chance to win the Best Paper Award, celebrating groundbreaking contributions to the field of cancer drug resistance.
We are pleased to announce a media partnership with the EMBO | EMBL Symposium - The ageing genome: from mechanisms to disease.
We sincerely thank all reviewers for their dedication and expertise, essential to CDR's growth and cancer drug resistance research.
Interview with Prof. David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment
On November 4, 2024, the editorial team sat down with Prof. David A. Gewirtz, a leading scientist in oncology research and an esteemed member of the journal’s Editorial Board.
Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]
NaN
Views: Downloads:
Adam Khorasanchi, ... Lingbin Meng
Views: Downloads:
Views: Downloads:
Chahat Suri, ... Henu Kumar Verma
Views: Downloads:
Bernhard Biersack, ... Michael Höpfner
Views: Downloads:
Views: Downloads:
Views: Downloads:
Vincenzo Sammartano, ... Alessandro Gozzetti
Views: Downloads:
Data
1847
Authors
3672
Reviewers
2018
Published Since
For Reviewers
For Readers
Add your e-mail address to receive forthcoming Issues of this journal:
Themed Collections
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Volume 8 (in progress)
Volume 7
Volume 6, Issue 4
Volume 6, Issue 3
Volume 6, Issue 2
Volume 6, Issue 1
Volume 5, Issue 4
Volume 5, Issue 3
Volume 5, Issue 2
Volume 5, Issue 1
Volume 4, Issue 4
Volume 4, Issue 3
Volume 4, Issue 2
Volume 4, Issue 1
Volume 3, Issue 4
Volume 3, Issue 3
Volume 3, Issue 2
Volume 3, Issue 1
Volume 2, Issue 4
Volume 2, Issue 3
Volume 2, Issue 2
Volume 2, Issue 1
Volume 1, Issue 4
Volume 1, Issue 3
Volume 1, Issue 2
Volume 1, Issue 1
Related Journals
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.
Authors of Review and Research Articles published in 2023-2024 have a chance to win the Best Paper Award, celebrating groundbreaking contributions to the field of cancer drug resistance.
We are pleased to announce a media partnership with the EMBO | EMBL Symposium - The ageing genome: from mechanisms to disease.
We sincerely thank all reviewers for their dedication and expertise, essential to CDR's growth and cancer drug resistance research.
Interview with Prof. David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment
On November 4, 2024, the editorial team sat down with Prof. David A. Gewirtz, a leading scientist in oncology research and an esteemed member of the journal’s Editorial Board.
Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]
NaN
Related Journals
Data
1847
Authors
3672
Reviewers
2018
Published Since